Navigation Links
Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
Date:5/6/2008

ARLINGTON, Va., May 6 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, announced today the completion of a Service Agreement with Concordia Pharmaceuticals, Inc. and initiation of preclinical studies to evaluate new applications for Salirasib using Champions Biotechnology's Biomerk Tumorgrafts(TM).

"Our Biomerk Tumorgraft preclinical platform and its benefits in drug discovery and evaluation is gaining recognition as we expand our platform to pharmaceutical and biotech companies" said Doug Burkett, Ph.D., President of Champions Biotechnology, Inc. "Champions is in a unique position to evaluate oncology drugs as well as novel drug combinations that may be effective in treating specific cancer types. We are pleased to be assisting Concordia Pharmaceuticals in the evaluation of new preclinical applications for Salirasib, a Ras-antagonist that acts to inhibit cancer by impairing the disease's ability to replicate defective cells."

For more information regarding Champions Biotechnology's growing business and recent news, please visit http://www.championsbiotechnology.com.

About Champions Biotechnology, Inc.

Champions Biotechnology, Inc. is engaged in the development of advanced preclinical platforms and predictive tumor specific data to enhance and accelerate the value of oncology drugs. The Company's Preclinical Platform is a novel approach based upon the implantation of primary human tumors in immune deficient mice followed by propagation of the resulting xenografts (Biomerk Tumorgrafts(TM)) in a manner that preserves the biological characteristics of the original human tumor. The Company believes that these Tumorgrafts closely reflect human cancer biology and their response to drugs is more predictive
'/>"/>

SOURCE Champions Biotechnology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
4. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... - Protecting the health and safety of Canadians is our government,s ... powers and tools at its disposal to help ensure that the ... To that end, Health Canada ... Canada of all drug products from three plants ... , Apotex Pharmachem India Pvt Ltd , Apotex Research ...
(Date:9/30/2014)... Sept. 30, 2014  Tasly Pharmaceuticals, Inc., the ... medicine, announced today the launch of Deepure. ... to address men and women concerned with supporting ... into old age while helping keep their health ... whole-food and herb-based formulas, namely, ProHeart PLUS, ImmunoPower ...
(Date:9/30/2014)... , Sept. 30, 2014  Decision Resources Group finds ... Brazil , Russia ... China (BRIC) will see robust expansion as ... favored over surgical procedures. Although revenues will be somewhat ... challenges, prolonged device approval times and demand for low-cost ...
Breaking Medicine Technology:Statement by the Honourable Rona Ambrose on the import ban of drug products from three plants in India 2Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 2Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 3
(Date:10/2/2014)... Thompson HealthDay Reporter ... pull out all the stops to rescue surgical patients ... the cost of such heroism is questionable, a new ... percent better at saving elderly patients with life-threatening complications ... less intensity, said senior author Dr. Amir Ghaferi. He ...
(Date:10/1/2014)... more than 80 per cent of bowel cancers could ... that medicines called ,JAK inhibitors, halted tumour growth in ... in more than 80 per cent of bowel cancers. ... clinical trials, for diseases including rheumatoid arthritis, psoriasis, blood ... second-most common cancer in Australia with nearly 17,000 people ...
(Date:10/1/2014)... 2014) Despite a policy focus on expanding ... this vulnerable population continues to have significant dental ... Journal of the American Dental Association , researchers ... University School of Dental Medicine report on the ... oral care provided by caregivers to adults with ...
(Date:10/1/2014)... Bedros Keuilian is not only the founder ... camps, he’s also considered the leading expert on marketing ... business summits, a line of high-demand fitness marketing systems ... Spike TV reality show to his name. , With ... for personal trainers and fitness business owners to focus ...
(Date:10/1/2014)... Conn. (PRWEB) October 01, 2014 ... company, including a redefined mission and visual identity ... power of partnering with them to create greater ... agile brand that focuses on empowering customers to ... communications. , The crown jewel of the rebrand ...
Breaking Medicine News(10 mins):Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Eighty percent of bowel cancers halted with existing medicines 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:Farmington Company Launches Rebrand and New Positioning 2
... University School of Medicine will add several new pediatric clinical rotations ... , ... North Brunswick, NJ (PRWEB) February 11, 2009-- ... will add several new pediatric clinical rotations to its growing network ...
... DaVita Inc.,(NYSE: DVA ) today announced results for ... the three months ended December 31, 2008 was $98.4,million, or ... per share,for the same period of 2007. , ... Net income for the year ended December 31, ...
... today reported significantly higher sales and earnings for both its fiscal third quarter and ... , Third quarter revenue increases 16% ... , Third quarter diluted EPS increases ... quarter of fiscal 2009, net sales increased 16 percent to $5,337,000 from $4,614,000 in ...
... First-Time AttendeesSTOWE, Vt., Feb. 10 The 9th Annual ... Learning for Survivors of All Cancers, and Those Who Love ... Stowe, Vermont, opens registration on February 24th, 2009.The Stowe ... has become one of the most inspiring, educational and unprecedented ...
... 10 Allscripts-Misys Healthcare,Solutions, Inc. ("Allscripts") announced today that ... under which Allscripts may purchase up to,$150 million of ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ... pursuant to Rule 10b5-1 or 10b-18 of the,Securities Exchange ...
... brain, researchers say , , TUESDAY, Feb. 10 (HealthDay News) ... don,t even bother to use them because they,re difficult ... nerves are allowing the brain to communicate directly with ... a banana and fold laundry. , "In the simplest ...
Cached Medicine News:Health News:Ross University School of Medicine Expands Clinical Rotations at Miami Children's Hospital 2Health News:DaVita 4th Quarter 2008 Results 2Health News:DaVita 4th Quarter 2008 Results 3Health News:DaVita 4th Quarter 2008 Results 4Health News:DaVita 4th Quarter 2008 Results 5Health News:DaVita 4th Quarter 2008 Results 6Health News:DaVita 4th Quarter 2008 Results 7Health News:DaVita 4th Quarter 2008 Results 8Health News:DaVita 4th Quarter 2008 Results 9Health News:DaVita 4th Quarter 2008 Results 10Health News:DaVita 4th Quarter 2008 Results 11Health News:DaVita 4th Quarter 2008 Results 12Health News:DaVita 4th Quarter 2008 Results 13Health News:DaVita 4th Quarter 2008 Results 14Health News:DaVita 4th Quarter 2008 Results 15Health News:DaVita 4th Quarter 2008 Results 16Health News:DaVita 4th Quarter 2008 Results 17Health News:DaVita 4th Quarter 2008 Results 18Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 2Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 3Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 4Health News:9th Annual Stowe Weekend of Hope Registration Opens February 24 2Health News:Allscripts Announces $150 Million Stock Repurchase Program and Increase in Credit Facility Commitments 2Health News:Allscripts Announces $150 Million Stock Repurchase Program and Increase in Credit Facility Commitments 3Health News:Allscripts Announces $150 Million Stock Repurchase Program and Increase in Credit Facility Commitments 4Health News:New Technology May Boost Artificial Arms 2
End-gripping forceps with small, concentric rings on each tip. For general purpose membrane grasping, particularly thin membranes, or grasping membranes adherent to the retinal surface....
... design and developmerit of systems for the ... is pleased to present its latest system ... in one compact system. The D.O.R.C. VFI/VFE ... such as silicone oil, with viscosities of ...
... The D.O.R.C. HEXON Illumination System ... Xenon systems offer, with one remarkable ... discharge lamp, a more efficient source ... illumination quality provides a color consistency ...
... The EndoProbe handpieces, used for ... active aspiration, 25 gauge, and illuminating ... provides the ophthalmologist with uncompromised laser ... have 3-meter, fiber-optic cables that are ...
Medicine Products: